SBIC is engaged in a network of intense collaborations with leading academic and R&D institutions in Singapore and overseas. Through the Joint Council Office grant initiative within A*STAR, SBIC has conducted 23 collaborative projects with 9 other A*STAR Institutes (SICS, IMB, BTI, GIS, IMCB, I2R, IME, IMRE, ICES)
Seven out the 10 Principal Investigators and Group leaders at SBIC have joint/adjunct faculty appointments with NUS (National University of Singapore), Duke-NUS and NTU (Nanyang Technology University) ensuring a productive interface with the academic institutions in Singapore. SBIC collaborates with other leading universities worldwide (Stanford, Harvard, MIT, Yale, Duke, Dartmouth, AMU, Oxford, Cambridge, Manchester, UCL,TUM, Graz) and research centers (Salk, Sanford-Burnham, XLIM-CNRS, CRMBM-CNRS, IBP-CAS, CAI-Brisbane).
In 2007, SBIC spearheaded the formation of the NUS-A*STAR Clinical Imaging Research Centre (CIRC) jointly with NUS and Siemens as the industry partner. CIRC has become a national resource for research imaging in humans open to all biomedical researchers in Singapore via the use of state-of-the- art instruments (MRI, PET-MR, PET-CT, SPECT-CT).
SBIC is also a partner of the KK Women's and Children's Hospital, the largest medical facility in Singapore providing specialist care for women and children. SBIC collaborates with KK Hospital’s Radiology Department on their high field MR imaging needs in research aligned to pathologies related to women and children.
SBIC pilots or participates in several research projects and protocols with other leading clinical institutions in Singapore at SingHealth, Duke-NUS and NUHS (National University Health System): the Clinical Nutrition Research Center, the National Cancer Centre, the National Neurology Institute, the National Skin Center, the National Heart Center of Singapore and the Cardiovascular Research Institute.
SBIC provides global biopharma/nutrition/personal care companies with a one-stop solution for all the preclinical imaging challenges they face. SBIC provides cutting edge research protocols and advanced multi-modal preclinical imaging capability to industrial standards, augmented, when necessary, with an expert input from SBIC scientists.
In parallel to this fee-for- service activity, SBIC is actively engaged in joint preclinical research protocols with leading multinational companies and SMEs specialising in pharmacology, nutrition, personal care, molecular probes (Bayer, Merck, Abbott, Danone, Mead-Johnson, Galderma, General Electric, Mundi-Pharma, Life Technologies, Johnson Matthey, Aspira, Inex, Matralix ...)
SBIC teams up with world leaders in the manufacturing and development of imaging instruments. It has entered a research cooperation agreement with Siemens Healthiners. SBIC also operates on its premises 5 joint laboratories under the framework of public-private partnerships with Nikon, Bruker, Mediso Ithera and MPA Inc.